Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Echocardiography, Stress | 6 | 2022 | 134 | 1.810 |
Why?
|
Heart Diseases | 5 | 2022 | 2809 | 0.530 |
Why?
|
Heart Transplantation | 3 | 2022 | 3224 | 0.500 |
Why?
|
Ventricular Outflow Obstruction | 2 | 2014 | 265 | 0.450 |
Why?
|
Ventricular Function, Right | 3 | 2014 | 610 | 0.410 |
Why?
|
Survivors | 5 | 2020 | 2375 | 0.390 |
Why?
|
Pyrroles | 5 | 2009 | 1137 | 0.390 |
Why?
|
Aortic Aneurysm, Thoracic | 1 | 2018 | 693 | 0.380 |
Why?
|
Anthracyclines | 4 | 2016 | 283 | 0.370 |
Why?
|
Cardiomyopathy, Hypertrophic | 1 | 2020 | 1311 | 0.370 |
Why?
|
Transplantation | 1 | 2012 | 218 | 0.350 |
Why?
|
Indoles | 5 | 2009 | 1829 | 0.340 |
Why?
|
Coronary Artery Disease | 3 | 2022 | 6659 | 0.330 |
Why?
|
Hodgkin Disease | 2 | 2014 | 1380 | 0.320 |
Why?
|
Genetic Association Studies | 1 | 2018 | 2716 | 0.310 |
Why?
|
Exercise Test | 2 | 2015 | 2128 | 0.300 |
Why?
|
Heart | 8 | 2015 | 4393 | 0.300 |
Why?
|
Echocardiography, Doppler | 1 | 2011 | 901 | 0.280 |
Why?
|
Antineoplastic Agents | 8 | 2012 | 13627 | 0.260 |
Why?
|
Radiation Injuries | 5 | 2015 | 1183 | 0.250 |
Why?
|
Protein Kinase Inhibitors | 3 | 2009 | 5640 | 0.230 |
Why?
|
Pulmonary Artery | 1 | 2012 | 1921 | 0.220 |
Why?
|
Cardiovascular Diseases | 6 | 2020 | 15760 | 0.200 |
Why?
|
Heart Defects, Congenital | 3 | 2015 | 4673 | 0.200 |
Why?
|
Antibiotics, Antineoplastic | 2 | 2016 | 675 | 0.200 |
Why?
|
Antibodies, Monoclonal | 2 | 2009 | 9185 | 0.190 |
Why?
|
Endocarditis, Bacterial | 1 | 2005 | 445 | 0.180 |
Why?
|
Stroke Volume | 4 | 2011 | 5523 | 0.180 |
Why?
|
Cardiac Surgical Procedures | 2 | 2014 | 3620 | 0.180 |
Why?
|
Blood Pressure | 3 | 2014 | 8525 | 0.180 |
Why?
|
Radiotherapy | 4 | 2015 | 1504 | 0.180 |
Why?
|
Heart Ventricles | 3 | 2020 | 3812 | 0.170 |
Why?
|
Propanolamines | 2 | 2016 | 162 | 0.170 |
Why?
|
Genetic Predisposition to Disease | 2 | 2018 | 17790 | 0.160 |
Why?
|
Heart Atria | 1 | 2005 | 1346 | 0.160 |
Why?
|
Echocardiography, Transesophageal | 1 | 2005 | 1108 | 0.160 |
Why?
|
Periventricular Nodular Heterotopia | 1 | 2018 | 53 | 0.150 |
Why?
|
Neoplasms | 7 | 2015 | 22075 | 0.150 |
Why?
|
Gastrointestinal Stromal Tumors | 3 | 2009 | 615 | 0.150 |
Why?
|
Mitral Valve Insufficiency | 2 | 2005 | 1419 | 0.140 |
Why?
|
Echocardiography | 10 | 2018 | 4981 | 0.140 |
Why?
|
Child | 12 | 2022 | 79799 | 0.140 |
Why?
|
Mitral Valve | 1 | 2005 | 1486 | 0.140 |
Why?
|
Coronary Angiography | 2 | 2022 | 4563 | 0.130 |
Why?
|
Respiration | 4 | 2000 | 1654 | 0.130 |
Why?
|
Carbazoles | 1 | 2016 | 220 | 0.120 |
Why?
|
Myocytes, Cardiac | 2 | 2022 | 1657 | 0.120 |
Why?
|
Hypertrophy, Left Ventricular | 2 | 2016 | 854 | 0.120 |
Why?
|
Follow-Up Studies | 8 | 2014 | 39262 | 0.120 |
Why?
|
Protein-Tyrosine Kinases | 3 | 2008 | 2418 | 0.110 |
Why?
|
Adrenergic beta-Antagonists | 2 | 2016 | 1259 | 0.110 |
Why?
|
Heart Failure | 4 | 2016 | 11848 | 0.110 |
Why?
|
Echocardiography, Doppler, Color | 3 | 2012 | 354 | 0.110 |
Why?
|
Microtubule-Associated Proteins | 1 | 2018 | 1078 | 0.110 |
Why?
|
Young Adult | 9 | 2018 | 58748 | 0.100 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2011 | 5659 | 0.100 |
Why?
|
DNA Damage | 1 | 2022 | 2442 | 0.100 |
Why?
|
Death, Sudden, Cardiac | 1 | 2020 | 1572 | 0.100 |
Why?
|
Ventricular Function, Left | 5 | 2016 | 3880 | 0.100 |
Why?
|
Adult | 21 | 2020 | 220007 | 0.100 |
Why?
|
Transposition of Great Vessels | 1 | 2015 | 590 | 0.090 |
Why?
|
Alternative Splicing | 1 | 2016 | 1091 | 0.090 |
Why?
|
Ventricular Remodeling | 2 | 2016 | 1261 | 0.090 |
Why?
|
Radiotherapy Planning, Computer-Assisted | 2 | 2015 | 1660 | 0.090 |
Why?
|
Humans | 42 | 2022 | 760613 | 0.090 |
Why?
|
Ventricular Function | 1 | 2012 | 408 | 0.090 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2020 | 1403 | 0.090 |
Why?
|
Child, Preschool | 7 | 2018 | 42056 | 0.090 |
Why?
|
Myocardial Ischemia | 3 | 2019 | 2164 | 0.090 |
Why?
|
Pulmonary Valve | 1 | 2014 | 414 | 0.090 |
Why?
|
Oxygen Consumption | 2 | 2015 | 1843 | 0.090 |
Why?
|
Neurogenesis | 1 | 2016 | 855 | 0.090 |
Why?
|
Male | 27 | 2020 | 359718 | 0.080 |
Why?
|
Female | 27 | 2020 | 391246 | 0.080 |
Why?
|
Epidermal Growth Factor | 1 | 2012 | 695 | 0.080 |
Why?
|
Neural Stem Cells | 1 | 2016 | 884 | 0.080 |
Why?
|
Exercise Tolerance | 1 | 2014 | 830 | 0.080 |
Why?
|
Infant, Newborn | 2 | 2020 | 26179 | 0.080 |
Why?
|
Breast | 1 | 1997 | 1963 | 0.080 |
Why?
|
Benzenesulfonates | 1 | 2009 | 165 | 0.080 |
Why?
|
Ventricular Dysfunction, Left | 2 | 2016 | 2128 | 0.080 |
Why?
|
Syncope | 2 | 2002 | 428 | 0.080 |
Why?
|
Adolescent | 8 | 2018 | 87809 | 0.080 |
Why?
|
Mediastinal Neoplasms | 1 | 2010 | 402 | 0.070 |
Why?
|
Societies, Medical | 1 | 2019 | 3905 | 0.070 |
Why?
|
Prognosis | 3 | 2022 | 29661 | 0.070 |
Why?
|
Niacinamide | 1 | 2009 | 414 | 0.070 |
Why?
|
Alleles | 1 | 2018 | 6900 | 0.070 |
Why?
|
Retrospective Studies | 6 | 2020 | 80345 | 0.070 |
Why?
|
Respiratory Physiological Phenomena | 1 | 1987 | 188 | 0.070 |
Why?
|
Dobutamine | 2 | 1996 | 116 | 0.070 |
Why?
|
Phenylurea Compounds | 1 | 2009 | 529 | 0.060 |
Why?
|
Ventricular Pressure | 2 | 2014 | 204 | 0.060 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2008 | 717 | 0.060 |
Why?
|
Transplantation, Homologous | 2 | 2012 | 4815 | 0.060 |
Why?
|
Risk Factors | 9 | 2016 | 74333 | 0.060 |
Why?
|
AMP-Activated Protein Kinases | 1 | 2009 | 600 | 0.060 |
Why?
|
Cardiotonic Agents | 2 | 2000 | 546 | 0.060 |
Why?
|
Middle Aged | 15 | 2018 | 220359 | 0.060 |
Why?
|
Posture | 2 | 2000 | 953 | 0.060 |
Why?
|
Cardiovascular System | 1 | 2012 | 850 | 0.060 |
Why?
|
Risk Assessment | 4 | 2016 | 24102 | 0.060 |
Why?
|
Cardiology | 1 | 2015 | 1723 | 0.060 |
Why?
|
Hemodynamics | 1 | 2014 | 4173 | 0.060 |
Why?
|
Heart Valve Prosthesis Implantation | 1 | 2014 | 1582 | 0.050 |
Why?
|
Medical Oncology | 1 | 2015 | 2313 | 0.050 |
Why?
|
Genotype | 1 | 2018 | 12957 | 0.050 |
Why?
|
Feasibility Studies | 3 | 2012 | 5201 | 0.050 |
Why?
|
Reproducibility of Results | 5 | 2012 | 20080 | 0.050 |
Why?
|
Dose-Response Relationship, Drug | 4 | 2009 | 10826 | 0.050 |
Why?
|
Prospective Studies | 5 | 2015 | 54306 | 0.050 |
Why?
|
Cardiomyopathies | 1 | 2015 | 1951 | 0.050 |
Why?
|
Boston | 2 | 2015 | 9278 | 0.050 |
Why?
|
Autonomic Nervous System | 2 | 1991 | 697 | 0.050 |
Why?
|
Multicenter Studies as Topic | 1 | 2007 | 1722 | 0.050 |
Why?
|
C-Reactive Protein | 1 | 2014 | 3839 | 0.050 |
Why?
|
Imaging, Three-Dimensional | 1 | 2015 | 4046 | 0.050 |
Why?
|
Dose-Response Relationship, Radiation | 2 | 2008 | 881 | 0.050 |
Why?
|
Hypothyroidism | 1 | 2006 | 665 | 0.050 |
Why?
|
Cell Survival | 2 | 2009 | 5797 | 0.050 |
Why?
|
Hypertension | 3 | 2014 | 8595 | 0.050 |
Why?
|
Heart Rate | 3 | 2015 | 4180 | 0.050 |
Why?
|
Blood Flow Velocity | 1 | 2005 | 1377 | 0.050 |
Why?
|
Severity of Illness Index | 2 | 2012 | 15840 | 0.050 |
Why?
|
Disease Management | 1 | 2012 | 2514 | 0.050 |
Why?
|
Lung | 2 | 2015 | 9994 | 0.050 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2008 | 1613 | 0.050 |
Why?
|
Cerebrovascular Disorders | 1 | 2008 | 1501 | 0.050 |
Why?
|
Diagnostic Imaging | 1 | 2015 | 3527 | 0.050 |
Why?
|
Hong Kong | 1 | 2020 | 162 | 0.050 |
Why?
|
Multivariate Analysis | 1 | 2014 | 12159 | 0.040 |
Why?
|
Predictive Value of Tests | 3 | 2015 | 15286 | 0.040 |
Why?
|
Cerebral Cortex | 1 | 2016 | 5761 | 0.040 |
Why?
|
Phenotype | 1 | 2018 | 16548 | 0.040 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 1987 | 1489 | 0.040 |
Why?
|
Aged | 10 | 2018 | 169143 | 0.040 |
Why?
|
Piperazines | 1 | 2009 | 2525 | 0.040 |
Why?
|
Atropine | 2 | 1996 | 245 | 0.040 |
Why?
|
Myocardium | 3 | 2009 | 4700 | 0.040 |
Why?
|
Signal Transduction | 3 | 2012 | 23374 | 0.040 |
Why?
|
Survival Analysis | 2 | 2009 | 10185 | 0.040 |
Why?
|
Infant | 2 | 2018 | 36053 | 0.040 |
Why?
|
Rats | 6 | 2009 | 23709 | 0.040 |
Why?
|
Neovascularization, Pathologic | 1 | 2008 | 2640 | 0.040 |
Why?
|
Sensitivity and Specificity | 2 | 2012 | 14661 | 0.040 |
Why?
|
Drug Delivery Systems | 1 | 2009 | 2221 | 0.040 |
Why?
|
Pyrimidines | 1 | 2009 | 3016 | 0.040 |
Why?
|
Pyridines | 1 | 2009 | 2879 | 0.040 |
Why?
|
Neurons | 1 | 2016 | 9424 | 0.040 |
Why?
|
Polypyrimidine Tract-Binding Protein | 1 | 2016 | 22 | 0.030 |
Why?
|
Survival Rate | 1 | 2011 | 12810 | 0.030 |
Why?
|
Heterogeneous-Nuclear Ribonucleoproteins | 1 | 2016 | 69 | 0.030 |
Why?
|
Cell Proliferation | 2 | 2009 | 10442 | 0.030 |
Why?
|
Radionuclide Angiography | 1 | 2015 | 23 | 0.030 |
Why?
|
Hypertrophy, Right Ventricular | 1 | 1996 | 106 | 0.030 |
Why?
|
Microsomes, Liver | 2 | 1975 | 173 | 0.030 |
Why?
|
Mitral Valve Prolapse | 1 | 1997 | 215 | 0.030 |
Why?
|
Centrosome | 1 | 2016 | 207 | 0.030 |
Why?
|
Inhalation | 1 | 2015 | 143 | 0.030 |
Why?
|
Mitral Valve Stenosis | 1 | 1997 | 348 | 0.030 |
Why?
|
Time Factors | 7 | 2016 | 40139 | 0.030 |
Why?
|
Tetrahydrofolate Dehydrogenase | 1 | 1975 | 133 | 0.030 |
Why?
|
Heart Aneurysm | 1 | 1994 | 115 | 0.030 |
Why?
|
Brain | 2 | 2018 | 26951 | 0.030 |
Why?
|
Breast Neoplasms | 2 | 2000 | 21029 | 0.030 |
Why?
|
Doxorubicin | 1 | 2020 | 2208 | 0.030 |
Why?
|
Organs at Risk | 1 | 2015 | 358 | 0.030 |
Why?
|
Positron-Emission Tomography | 1 | 2009 | 6465 | 0.030 |
Why?
|
Blood Volume | 1 | 1994 | 550 | 0.030 |
Why?
|
Myocardial Contraction | 2 | 2014 | 1516 | 0.030 |
Why?
|
Heart Septal Defects, Atrial | 1 | 1995 | 461 | 0.030 |
Why?
|
Adaptation, Physiological | 1 | 1998 | 1296 | 0.020 |
Why?
|
Protein Isoforms | 1 | 2016 | 1697 | 0.020 |
Why?
|
Cell Line, Tumor | 1 | 2008 | 16932 | 0.020 |
Why?
|
Coronary Disease | 2 | 1996 | 5991 | 0.020 |
Why?
|
Heterozygote | 1 | 2018 | 2798 | 0.020 |
Why?
|
Oxidative Stress | 1 | 2022 | 3106 | 0.020 |
Why?
|
Hemoglobins | 2 | 1975 | 1521 | 0.020 |
Why?
|
Cytoskeletal Proteins | 1 | 2016 | 1344 | 0.020 |
Why?
|
Clinical Protocols | 1 | 2016 | 1440 | 0.020 |
Why?
|
Blood Circulation | 1 | 1991 | 249 | 0.020 |
Why?
|
NADP | 3 | 1975 | 223 | 0.020 |
Why?
|
Coronary Circulation | 1 | 1996 | 1577 | 0.020 |
Why?
|
Hydrogen-Ion Concentration | 6 | 1975 | 2502 | 0.020 |
Why?
|
Exons | 1 | 2016 | 2389 | 0.020 |
Why?
|
Drug Administration Schedule | 2 | 2009 | 4899 | 0.020 |
Why?
|
Cardiovascular Physiological Phenomena | 1 | 1991 | 239 | 0.020 |
Why?
|
Magnetic Resonance Angiography | 1 | 1997 | 1431 | 0.020 |
Why?
|
Early Diagnosis | 1 | 2015 | 1180 | 0.020 |
Why?
|
Postoperative Complications | 1 | 2012 | 15679 | 0.020 |
Why?
|
Animals | 14 | 2016 | 167960 | 0.020 |
Why?
|
Tumor Burden | 1 | 2015 | 1895 | 0.020 |
Why?
|
Mediastinum | 1 | 2010 | 266 | 0.020 |
Why?
|
Heart Valve Diseases | 1 | 1997 | 1047 | 0.020 |
Why?
|
Cohort Studies | 1 | 2012 | 41337 | 0.020 |
Why?
|
Mice | 4 | 2016 | 81209 | 0.020 |
Why?
|
Radiotherapy, Intensity-Modulated | 1 | 2015 | 801 | 0.020 |
Why?
|
Linear Models | 2 | 2015 | 5877 | 0.020 |
Why?
|
Age Factors | 2 | 2016 | 18413 | 0.020 |
Why?
|
Radiotherapy Dosage | 1 | 2015 | 2897 | 0.020 |
Why?
|
International Cooperation | 1 | 2015 | 1433 | 0.020 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 1 | 2015 | 1214 | 0.020 |
Why?
|
Folic Acid Deficiency | 1 | 1979 | 117 | 0.020 |
Why?
|
Inhibitory Concentration 50 | 1 | 2009 | 465 | 0.020 |
Why?
|
Sex Characteristics | 1 | 1998 | 2629 | 0.020 |
Why?
|
Treatment Outcome | 4 | 2016 | 64981 | 0.020 |
Why?
|
Membrane Potential, Mitochondrial | 1 | 2009 | 296 | 0.020 |
Why?
|
Cooperative Behavior | 1 | 2015 | 1500 | 0.020 |
Why?
|
NAD | 2 | 1975 | 609 | 0.020 |
Why?
|
Thyroiditis | 1 | 2006 | 86 | 0.020 |
Why?
|
Supine Position | 1 | 1987 | 205 | 0.020 |
Why?
|
Streptomyces griseus | 1 | 1975 | 5 | 0.020 |
Why?
|
Hemerythrin | 1 | 1975 | 5 | 0.020 |
Why?
|
Hospitals, Pediatric | 1 | 2015 | 1854 | 0.020 |
Why?
|
Hexosaminidases | 1 | 1975 | 45 | 0.020 |
Why?
|
Isocarboxazid | 1 | 1975 | 7 | 0.020 |
Why?
|
Digitoxin | 1 | 1975 | 19 | 0.020 |
Why?
|
Glutamate Dehydrogenase | 1 | 1975 | 50 | 0.020 |
Why?
|
Acetylglucosaminidase | 1 | 1975 | 67 | 0.020 |
Why?
|
Data Collection | 1 | 2015 | 3315 | 0.020 |
Why?
|
Lung Volume Measurements | 1 | 1987 | 376 | 0.020 |
Why?
|
Capillaries | 1 | 2009 | 744 | 0.020 |
Why?
|
Pepsin A | 1 | 1975 | 66 | 0.020 |
Why?
|
Procaine | 1 | 1975 | 60 | 0.020 |
Why?
|
Esterases | 1 | 1975 | 97 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-kit | 1 | 2009 | 727 | 0.020 |
Why?
|
Metalloproteins | 1 | 1975 | 101 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 3 | 2018 | 36286 | 0.020 |
Why?
|
Coronary Vessels | 1 | 1997 | 3112 | 0.020 |
Why?
|
Consensus | 1 | 2015 | 3113 | 0.020 |
Why?
|
Ifosfamide | 1 | 1975 | 232 | 0.020 |
Why?
|
Systole | 2 | 1998 | 947 | 0.020 |
Why?
|
Carcinosarcoma | 1 | 1975 | 104 | 0.020 |
Why?
|
Myocardial Infarction | 2 | 1997 | 11890 | 0.020 |
Why?
|
Aged, 80 and over | 5 | 2015 | 58980 | 0.010 |
Why?
|
Amidohydrolases | 1 | 1975 | 162 | 0.010 |
Why?
|
Sesquiterpenes | 1 | 1975 | 176 | 0.010 |
Why?
|
Uridine | 1 | 1975 | 143 | 0.010 |
Why?
|
Databases, Factual | 2 | 2015 | 8022 | 0.010 |
Why?
|
Longitudinal Studies | 2 | 2015 | 14494 | 0.010 |
Why?
|
Oxygen | 1 | 1975 | 4193 | 0.010 |
Why?
|
Electrocardiography | 3 | 1998 | 6415 | 0.010 |
Why?
|
Benzamides | 1 | 2009 | 1369 | 0.010 |
Why?
|
Recovery of Function | 1 | 2014 | 2985 | 0.010 |
Why?
|
Age of Onset | 1 | 2010 | 3302 | 0.010 |
Why?
|
Aging | 1 | 2022 | 8652 | 0.010 |
Why?
|
Treatment Failure | 1 | 2009 | 2647 | 0.010 |
Why?
|
Urea | 1 | 1975 | 446 | 0.010 |
Why?
|
Thyrotropin | 1 | 2006 | 832 | 0.010 |
Why?
|
Sheep | 2 | 1996 | 1441 | 0.010 |
Why?
|
Evidence-Based Medicine | 1 | 2015 | 3696 | 0.010 |
Why?
|
Multiprotein Complexes | 1 | 2009 | 1120 | 0.010 |
Why?
|
RNA, Transfer | 1 | 1975 | 289 | 0.010 |
Why?
|
Recurrence | 3 | 2002 | 8483 | 0.010 |
Why?
|
Antipsychotic Agents | 1 | 1976 | 3061 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2016 | 12427 | 0.010 |
Why?
|
Spectrum Analysis | 2 | 1991 | 453 | 0.010 |
Why?
|
Nuclear Proteins | 1 | 2016 | 5795 | 0.010 |
Why?
|
Spectrophotometry, Ultraviolet | 3 | 1975 | 201 | 0.010 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2009 | 2007 | 0.010 |
Why?
|
Kinetics | 4 | 1975 | 6377 | 0.010 |
Why?
|
Research Design | 1 | 2016 | 6180 | 0.010 |
Why?
|
Dogs | 2 | 1996 | 3841 | 0.010 |
Why?
|
Muscle Proteins | 1 | 1975 | 1152 | 0.010 |
Why?
|
Streptococcus pneumoniae | 1 | 1975 | 732 | 0.010 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2009 | 2058 | 0.010 |
Why?
|
Cyclophosphamide | 1 | 1975 | 2222 | 0.010 |
Why?
|
Catheterization | 2 | 1995 | 1432 | 0.010 |
Why?
|
Incidence | 2 | 2012 | 21391 | 0.010 |
Why?
|
Immunity | 1 | 1975 | 998 | 0.010 |
Why?
|
Graft Rejection | 1 | 2012 | 4426 | 0.010 |
Why?
|
Ligands | 2 | 1975 | 3276 | 0.010 |
Why?
|
Cardiac Output, Low | 1 | 1998 | 192 | 0.010 |
Why?
|
Mutation | 1 | 2022 | 29957 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 1 | 2009 | 8158 | 0.010 |
Why?
|
Stroke | 1 | 2000 | 9952 | 0.010 |
Why?
|
Tricuspid Valve Stenosis | 1 | 1997 | 27 | 0.010 |
Why?
|
Ultrasonography, Interventional | 2 | 1996 | 1501 | 0.010 |
Why?
|
Sex Distribution | 1 | 2002 | 2294 | 0.010 |
Why?
|
Schizophrenia | 1 | 1976 | 6915 | 0.010 |
Why?
|
Biopsy | 1 | 2009 | 6771 | 0.010 |
Why?
|
Species Specificity | 3 | 1975 | 2418 | 0.010 |
Why?
|
Colitis, Ulcerative | 1 | 1979 | 1919 | 0.010 |
Why?
|
Age Distribution | 1 | 2002 | 2893 | 0.010 |
Why?
|
Proteins | 2 | 2009 | 6029 | 0.010 |
Why?
|
Promazine | 1 | 1976 | 4 | 0.010 |
Why?
|
Binding Sites | 2 | 1975 | 6048 | 0.010 |
Why?
|
Trifluoperazine | 1 | 1976 | 37 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 2 | 2015 | 20509 | 0.010 |
Why?
|
Crohn Disease | 1 | 1979 | 2275 | 0.010 |
Why?
|
Swine | 2 | 1996 | 5899 | 0.010 |
Why?
|
Diastole | 1 | 1998 | 788 | 0.010 |
Why?
|
Chlorpromazine | 1 | 1976 | 111 | 0.010 |
Why?
|
Mitochondria | 1 | 2009 | 3601 | 0.010 |
Why?
|
Proportional Hazards Models | 2 | 2002 | 12531 | 0.010 |
Why?
|
Cobalt | 1 | 1975 | 155 | 0.010 |
Why?
|
Basal Ganglia Diseases | 1 | 1976 | 144 | 0.010 |
Why?
|
Folic Acid | 2 | 1979 | 1309 | 0.010 |
Why?
|
Cardiac Volume | 1 | 1996 | 199 | 0.010 |
Why?
|
Folic Acid Antagonists | 1 | 1975 | 75 | 0.010 |
Why?
|
Oxyhemoglobins | 1 | 1975 | 212 | 0.010 |
Why?
|
Rats, Wistar | 1 | 1998 | 1849 | 0.010 |
Why?
|
Mathematics | 1 | 1975 | 707 | 0.010 |
Why?
|
Protein Conformation | 2 | 1975 | 3970 | 0.010 |
Why?
|
Protein Binding | 2 | 1975 | 9335 | 0.010 |
Why?
|
Tricuspid Valve Insufficiency | 1 | 1997 | 355 | 0.010 |
Why?
|
Movement Disorders | 1 | 1976 | 459 | 0.010 |
Why?
|
United States | 1 | 2019 | 72448 | 0.010 |
Why?
|
Lactic Acid | 1 | 1996 | 1134 | 0.010 |
Why?
|
Chi-Square Distribution | 1 | 1997 | 3465 | 0.010 |
Why?
|
Observer Variation | 1 | 1996 | 2601 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2009 | 22020 | 0.010 |
Why?
|
Structure-Activity Relationship | 2 | 1975 | 3085 | 0.010 |
Why?
|
Liver | 1 | 1975 | 7510 | 0.010 |
Why?
|
Propranolol | 1 | 1991 | 489 | 0.010 |
Why?
|
Megaloblasts | 1 | 1979 | 1 | 0.010 |
Why?
|
Erythrocyte Aging | 1 | 1979 | 53 | 0.010 |
Why?
|
Transcription Factors | 1 | 2009 | 12102 | 0.010 |
Why?
|
Temperature | 2 | 1975 | 2221 | 0.000 |
Why?
|
Sulfasalazine | 1 | 1979 | 84 | 0.000 |
Why?
|
Analysis of Variance | 1 | 1997 | 6238 | 0.000 |
Why?
|
Artifacts | 1 | 1997 | 1898 | 0.000 |
Why?
|
Alcohol Drinking | 1 | 2000 | 4013 | 0.000 |
Why?
|
Reference Values | 1 | 1994 | 4925 | 0.000 |
Why?
|
Massachusetts | 1 | 2000 | 8803 | 0.000 |
Why?
|
Iron | 1 | 1975 | 1786 | 0.000 |
Why?
|
Cnidaria | 1 | 1975 | 14 | 0.000 |
Why?
|
Mortality | 1 | 1997 | 2916 | 0.000 |
Why?
|
Digitoxigenin | 1 | 1975 | 9 | 0.000 |
Why?
|
Lethal Dose 50 | 1 | 1975 | 72 | 0.000 |
Why?
|
Chromatography, Thin Layer | 1 | 1975 | 212 | 0.000 |
Why?
|
Trichloroacetic Acid | 1 | 1975 | 48 | 0.000 |
Why?
|
Hydroxylation | 1 | 1975 | 137 | 0.000 |
Why?
|
Stimulation, Chemical | 1 | 1975 | 306 | 0.000 |
Why?
|
Ketoglutaric Acids | 1 | 1975 | 75 | 0.000 |
Why?
|
Drug Combinations | 1 | 1991 | 2025 | 0.000 |
Why?
|
Models, Molecular | 2 | 1975 | 5434 | 0.000 |
Why?
|
Erythrocyte Count | 1 | 1975 | 157 | 0.000 |
Why?
|
Logistic Models | 1 | 2000 | 13312 | 0.000 |
Why?
|
Fucose | 1 | 1975 | 122 | 0.000 |
Why?
|
Methods | 1 | 1975 | 1074 | 0.000 |
Why?
|
Plants, Medicinal | 1 | 1975 | 166 | 0.000 |
Why?
|
Triticum | 1 | 1975 | 89 | 0.000 |
Why?
|
Fourier Analysis | 1 | 1975 | 439 | 0.000 |
Why?
|
Subcellular Fractions | 1 | 1975 | 532 | 0.000 |
Why?
|
Molecular Conformation | 1 | 1975 | 548 | 0.000 |
Why?
|
Drug Tolerance | 1 | 1975 | 369 | 0.000 |
Why?
|
Spectrometry, Fluorescence | 1 | 1975 | 687 | 0.000 |
Why?
|
Oligosaccharides | 1 | 1975 | 405 | 0.000 |
Why?
|
Plants | 1 | 1975 | 317 | 0.000 |
Why?
|
Computers | 1 | 1975 | 595 | 0.000 |
Why?
|
Case-Control Studies | 1 | 2000 | 22052 | 0.000 |
Why?
|
Phospholipids | 1 | 1975 | 789 | 0.000 |
Why?
|
Leukocyte Count | 1 | 1975 | 1599 | 0.000 |
Why?
|
Bone Marrow Cells | 1 | 1979 | 2414 | 0.000 |
Why?
|
Tyrosine | 1 | 1975 | 1438 | 0.000 |
Why?
|
Metals | 1 | 1975 | 736 | 0.000 |
Why?
|
Chronic Disease | 1 | 1976 | 9288 | 0.000 |
Why?
|
Neoplasms, Experimental | 1 | 1975 | 1229 | 0.000 |
Why?
|
Drug Evaluation, Preclinical | 1 | 1975 | 1347 | 0.000 |
Why?
|
Cattle | 1 | 1975 | 3847 | 0.000 |
Why?
|
Image Processing, Computer-Assisted | 1 | 1997 | 8950 | 0.000 |
Why?
|
Clinical Trials as Topic | 1 | 1976 | 8055 | 0.000 |
Why?
|
Oxidation-Reduction | 1 | 1975 | 2222 | 0.000 |
Why?
|
Erythrocytes | 1 | 1979 | 2415 | 0.000 |
Why?
|
Bone Marrow | 1 | 1979 | 2914 | 0.000 |
Why?
|
Hyperglycemia | 1 | 1975 | 1380 | 0.000 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 1975 | 3765 | 0.000 |
Why?
|
Algorithms | 1 | 1996 | 13982 | 0.000 |
Why?
|
Saccharomyces cerevisiae | 1 | 1975 | 2698 | 0.000 |
Why?
|